Provera 10 mg Duration for Stopping Bleeding
For abnormal uterine bleeding, Provera (medroxyprogesterone acetate) 10 mg should be taken daily for 5 to 10 days to achieve cessation of bleeding. 1
Dosing Algorithm Based on Clinical Context
For Acute Abnormal Uterine Bleeding
- Standard regimen: 5-10 mg daily for 5-10 days 1
- Optimal endometrial transformation: 10 mg daily for 10 days provides the most complete secretory transformation when the endometrium has been adequately primed with estrogen 1
- Expected bleeding response: Withdrawal bleeding typically occurs within 3-7 days after discontinuing therapy 1, 2
For Secondary Amenorrhea (Inducing Withdrawal Bleeding)
- Dosing: 5-10 mg daily for 5-10 days 1
- Preferred dose: 10 mg daily for 10 days achieves optimal secretory transformation 1
- Timing: Can be started at any time in cases of secondary amenorrhea 1
- Success rate: 93% of women experience withdrawal bleeding with this regimen 2
For Endometrial Protection in Hormone Replacement Therapy
- Dosing: 5-10 mg daily for 12-14 consecutive days per month 1
- Context: Used in postmenopausal women receiving daily conjugated estrogens 3
- Bleeding cessation timeline: 80% of women achieve amenorrhea by 6 months when used continuously 4
Clinical Evidence Supporting Duration
The FDA-approved labeling clearly specifies 5-10 days as the treatment duration for both abnormal uterine bleeding and secondary amenorrhea 1. This is supported by multiple guidelines showing that medroxyprogesterone acetate (MPA) 10 mg daily for 10-14 days provides adequate endometrial protection and induces withdrawal bleeding 5, 3.
Research demonstrates that 10 mg daily for 10 days is the optimal dose for inducing secretory transformation of the endometrium 1. A randomized trial showed that both 10 mg and 20 mg doses achieved bleeding cessation with a median time of 3 days, with 76% stopping bleeding within the treatment period 6.
Important Clinical Considerations
Bleeding pattern expectations:
- Withdrawal bleeding occurs 3-7 days after stopping medication 1, 2
- If no bleeding occurs after the progestin challenge, this may indicate inadequate estrogen priming or outflow tract obstruction 7
- Endometrial thickness >5mm on ultrasound correlates significantly with successful withdrawal bleeding 2
When to use longer duration (12-14 days):
- Hormone replacement therapy context requiring endometrial protection 5
- Recurrent episodes of abnormal bleeding may benefit from planned menstrual cycling 1
Common pitfall to avoid: Do not use shorter courses (e.g., 5 days) as initial therapy for abnormal bleeding when adequate endometrial transformation is needed. The 10-day regimen at 10 mg daily provides superior endometrial protection and more predictable withdrawal bleeding 1.
Starting dose recommendation: Begin with the lowest effective dose and adjust based on response, but recognize that 10 mg daily for 10 days is the established optimal regimen for inducing complete secretory transformation 1.